By Matthew Roscoe • 22 February 2022 • 9:58
JOHNSON & Johnson‘s Janssen vax could be pulled from use in France following a worrying link to a rise in heart issues after receiving the jab, according to France’s medical authority.
On Monday, February 21, France’s High Authority for Health (HAS) recommended that the Janssen vaccine only be reserved for certain people at risk of severe forms of Covid, pending the conclusions of an investigation by the European Medicines Agency (EMA), who are studying a link between the vaccine and heart issues.
Thank you for taking the time to read this article, do remember to come back and check The Euro Weekly News website for all your up-to-date local and international news stories and remember, you can also follow us on Facebook and Instagram.
Share this story
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don’t already have one. Review our
Originally from the UK, Matthew is based on the Costa Blanca and is a web reporter for The Euro Weekly News covering international and Spanish national news. Got a news story you want to share? Then get in touch at [email protected]
Your email address will not be published. Required fields are marked *
Downlaod our media pack in either English or Spanish.